The infection for each of the experiments with VACV was done at the same viral titer (Fig. 7C and D; MOI 0.0003); however, we did not see a significant change in the number of infections when treated with S protein in comparison to when treated with TGF-β (Fig. S6C and E). The gene discussed is TGFB1; the disease is infection.